Search Weight Loss Topics:

Page 1,280«..1020..1,2791,2801,2811,282..1,2901,300..»

Half of Irish people find information on climate action confusing – SFI – TechCentral.ie

Posted: November 12, 2019 at 2:48 pm

Research conducted as part of Science Week, which runs from 10-17 November

Print

Read More: climate change research Science Foundation Ireland Science Week sustainability

Research from Science Foundation Ireland (SFI) found that 49% of Irish people find information on climate action confusing and unclear.

As part of the currently ongoing Science Week 2019, SFI commissioned iReach Insights to investigate the Irish publics understanding and awareness of climate change. It identified what the public are willing to do to make a positive climate impact and what they understand to be the biggest changes they can make as individuals. This research aligns with the central theme of this years Science Week: climate action.

The vast majority (86%) of participants studied agreed that climate change is mostly due to human activity. This belief is most common among younger participants, in fact 91% of 18-34-year-olds agreed with the statement. Plus, 88% agreed that the earth is getting warmer as a result of climate change.

In terms of making a personal impact, 74% of respondents said they would be willing to use reusable drinking bottles, coffee cups or shopping bags, while 73% could commit to reducing their food waste. While 36% would reduce their meat consumption, 10% would eat a plant-based diet to make a positive environmental contribution.

Respondents believe they can make the biggest personal impact by using energy efficient products in their home (55%); using reusable drink containers or shopping bags (49%); and by cycling, walking or using public transport more (49%).

Science Week 2019 is already in full bloom, having kicked off on 10 November. Hundreds of events will take place over the course of the week to bring science and climate action to the fore of the Irish publics minds.

Climate change is the biggest crisis facing humanity today. Climate disruption is already having diverse and wide-ranging impacts on Irelands environment, society, economic and natural resources. It is changing where people, plants and animals can safely live, and the recent media and policy focus on climate emergency and action is to be welcomed, said Prof Mark Ferguson, director general, SFI and chief scientific adviser to the government of Ireland.

As part of Science Week 2019, we are seeking to help people understand climate change, how science and technology can help us create a positive climate future and the impact we as individuals can have on climate change. Given that a significant majority of our research respondents stated that they find information on climate action confusing, we hope to provide research-based information and solutions as part of Science Week 2019.

Reducing plastics is only one of a multitude of actions required, we need to widen the engagement with the public in relation to solutions to greenhouse emission and climate action.

For more information about Science Week visit: http://www.scienceweek.ie

TechCentral Reporters

Read More: climate change research Science Foundation Ireland Science Week sustainability

Read the original post:
Half of Irish people find information on climate action confusing - SFI - TechCentral.ie

Women’s Health: How to treat symptoms of menopause – GazetteNET

Posted: November 12, 2019 at 2:47 pm

Menopause is not a disease or a disorder. The transition to menopause is a point in time 12 months after a persons last period. After this transition, many feel they no longer need to worry about painful periods and uncomfortable cramps, and they no longer can become pregnant. Menopause impacts everyone differently. There are many factors to consider when thinking about how you and your health care provider treat the symptoms of menopause.

Transitioning to menopause most often begins between the ages of 45 and 55. Menopause occurs when the ovaries, which have ovulated monthly since puberty, run out of eggs. The ovaries create three primary hormones: estradiol, progesterone and testosterone, which run the menstrual cycle and have many effects throughout the body. Menopause creates a deficiency in all three sex hormones, with immediate and long-term effects.

The short-term symptoms are well known, including hot flashes, disrupted sleep (from hot flashes), altered mood and concentration (due to disrupted sleep), vulvar and vaginal dryness, and the loss of libido and sexual pleasure.

One approach to treatment is restoring the missing hormones with hormone replacement therapy, HRT. HRT became prevalent in the 1970s. In the last 30 years, there has been controversy as to the value, safety and public health benefits of estrogen therapy. Long-term studies show that HRT can be safely given without increasing overall risk of disease. This is a nuanced therapy, however. Current evidence shows that HRT has overall health benefits, if started within the decade after menopause that the risk of complications from taking HRT for 5 to ten years is very low. If started after that, when atherosclerosis (hardening of the arteries) and other diseases have begun, the benefits are less and harms are more evident.

Some cannot use estrogens safely and must have alternate treatments. These include people with histories of hormone-sensitive breast cancer, spontaneous clots in their veins (venous thrombosis), or active liver disease.

Fortunately, there are alternatives to HRT. Non-hormonal therapies for each of the symptoms of menopause are readily available.

For hot flashes, lifestyle changes such as wearing less nightclothes, sleeping on a regular schedule, getting regular exercise, and taking certain supplements can be helpful. Also, eat a balanced diet and avoid stimulants, such as caffeine.

If these approaches dont work, several non-hormonal therapies can block hot flashes, including the anti-depressants venlafaxine, fluoxetine and paroxetine. Only paroxetine is FDA approved for this purpose. My experience is that venlafaxine works best and at very low doses; a dose of 37.5 mg will block flashes, while depression usually requires 150-225 mg. Two anti-hypertensives, methyldopa and clonidine, are also effective.

I will often suggest to the patients internist that someone diagnosed with hypertension (high blood pressure) who experiences bad hot flashes be switched to one of these drugs in order to get the hot-flash blocking effect. Gabapentin, an anti-epileptic medication, also blocks flashes. It also has the potential for other side effects including drowsiness and can cause some people to become dependent on the medication. People who use it for other reasons often find their flashes improve.

Those who use thyroid medication, Ritalin or Adderall, and who are having flashes should have their doses kept low. As with any change in medication, speak with your health care provider to understand all of the benefits and risks.

To treat dryness, lubricants, application of topical oils, pelvic floor exercises and regular intercourse help to maintain skin and muscle tone, improve sexual comfort and increase vaginal moisture but do not reverse atrophy.

Oils are mostly useful for those with mild symptoms. Oils are applied lightly at the introitus (the opening of the vagina) and gently rubbed into the skin. I advise patients to do this twice a day. Virgin olive oil, coconut butter or oil and almond oil are all effective.

Commercial vaginal moisturizers are widely available in pharmacies and online and should be used two or three days per week, not just during sexual activity. Lubricants are used only during sexual activity and work best when applied to both partners.

While estrogens are the most effective medical therapy, hormonal medications other than estrogen are also available for genitourinary syndrome of menopause, a variety of symptoms that affect the genital and urinary systems.

Laser phototherapy promotes healthy skin

Since 2014, gynecologists have used fractional CO2 laser phototherapy to treat vulvo-vaginal dryness.

Phototherapy exposes the vaginal and vulvar skin to a specific wavelength of light, which stimulates the growth of healthy skin and connective tissue. Despite the word laser, this is not a beam and it does not cut or burn.

Phototherapy is administered by a probe that delivers the light in a diffuse grid to the entire vaginal vault. Growth of healthy skin and connective tissue are imperceptible to the patient but begin within two weeks of therapy. Three treatments are given at monthly intervals. My experience with phototherapy is that virtually all patients regain normal vaginal health within three months, including the ability to have comfortable intercourse and in many cases, correction of urinary incontinence.

The effects of phototherapy last for two or more years. Phototherapy effectively treats vulvovaginal dryness and discomfort, tissue fragility and painful sex (dyspareunia). There are no known risks of phototherapy.

As you or someone you love approaches the onset of the menopausal transition, its important to remember that the outlook for those at this stage of life is generally positive. We can safely treat most people with thoughtful use of estrogens. For those who decline, cannot take or are unable to benefit from such therapy, there are good alternatives for virtually all of the symptoms. Have a conversation with your health care provider to learn more about your options.

Read the rest here:
Women's Health: How to treat symptoms of menopause - GazetteNET

Testosterone Replacement Therapy Industry: Time to Invest in emerging Markets | Endo International, Pfizer, Novartis – News Description

Posted: November 12, 2019 at 2:47 pm

AMA recently published a detailed study of over 180+ pages in its repository on Testosterone Replacement Therapy market covering interesting aspects of market with supporting development scenario till 2025. The study provides market size break-up by revenue and volume* for emerging countries and important business segments along with commentary on trending factors, growth drivers. Profiled players in study from the coverage used under bottom-up approach are AbbVie Inc. (United States), Endo International (Ireland), Eli Lilly and Company (United States), Pfizer (United States), Bayer (Germany), Actavis (Allergan) (United States), Novartis (Switzerland), Teva (Israel), Ferring Pharmaceuticals (Switzerland), Kyowa Kirin (Japan), Mylan (United States)

Next step one should take to boost sales? Track latest strategic steps and current scenario analysis of the market @ https://www.advancemarketanalytics.com/sample-report/46424-global-testosterone-replacement-therapy-market

Testosterone is responsible for the development of male sexual characteristics and this hormone formed by the testicles. Insufficient production of testosterone causes erectile dysfunction. Testosterone Replacement Therapy (TRT) is generally termed as hormone therapy for men, designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is clinical syndrome, which results in the failure of the testes to produce physiological levels of testosterone. Erectile dysfunction arises due to reduce testosterone production to overcome this testosterone replacement therapy is used to improve the problem.

Market Segmentationby Type (Creams or Gels, Patches, Injections, Buccal Adhesives, Implants, Oral), Application (Hospitals, Clinics)

Make an enquiry before buying this Report @ https://www.advancemarketanalytics.com/enquiry-before-buy/46424-global-testosterone-replacement-therapy-market

Whats Trending in Market: Increasing awareness about testosterone substitute therapy

Growth Drivers: Increasing prevalence of hypogonadism in adult men

The need for having an offspring amongst men

Restraints: High possibility of side effects related to testosterone replacement therapy

View Detailed Table of Content @ https://www.advancemarketanalytics.com/reports/46424-global-testosterone-replacement-therapy-market

Country level Break-up includes:North America (United States, Canada and Mexico)Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)

Try a limited scope research document specific to Country or Regional matching your objective.

GET FULL COPY OF United States Testosterone Replacement Therapy market study @ USD 2000

And, Europe Testosterone Replacement Therapy market study @ USD 2500 Major Highlights of TOC:

Chapter One: Market Overview

Scope/Objective of the Study

Chapter Two: Executive Summary - Free of Cost

Chapter Three: Market Dynamics USD400

Market Drivers, Market Challenges, Market Trends

Chapter Four: Market Factor Analysis USD400

Supply/Value Chain Analysis, Porters Five Forces, PESTEL analysis, Market Entropy, Patent & Trademark Analysis, Market Development Scenario

Chapter Five and Seven: Global Testosterone Replacement Therapy, by Market Segmentation and Region (value, volume**) (2013-2024) USD2400

Global Testosterone Replacement Therapy

By Type (Creams or Gels, Patches, Injections, Buccal Adhesives, Implants, Oral)

By Application (Hospitals, Clinics)

Global Testosterone Replacement Therapy Region

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Netherlands, Switzerland, Nordic, Others)

Asia-Pacific (Japan, China, Australia, India, Taiwan, South Korea, Middle East & Africa, Others)

Chapter Six: Global Testosterone Replacement Therapy Manufacturers/Players Analysis USD1200

Competitive Landscape (Direct & Indirect Competitors), Market Share Analysis, Peer Group Analysis (2018), BCG Matrix, Company Profile, Downstream Buyers & Upstream Suppliers

..

Chapter Nine: Methodology/Research Approach, Data Source, Disclaimer

** If applicable

* Customized Section/Chapter wise Reports or Regional or Country wise Chapters are also available.

Buy this report @ https://www.advancemarketanalytics.com/buy-now?format=1&report=46424

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Contact Us: CRAIG FRANCIS (PR & Marketing Manager)[emailprotected]Ph: +1 (206) 317 1218

Original post:
Testosterone Replacement Therapy Industry: Time to Invest in emerging Markets | Endo International, Pfizer, Novartis - News Description

Testosterone Replacement Therapy Market 2019-2027 Onset of Advanced Technologies to Upsurge the Growth – The Denton Chronicle

Posted: November 12, 2019 at 2:47 pm

The Testosterone Replacement Therapy Market Report is a valuable source of information for corporate strategists. This study contains comprehensive data that enhances the understanding, scope and application of this report. The report contains all the necessary information about the latest innovations, such as: For example, Porters five-pot model analysis and advanced profiles of elite industry participants.

The major players in the Testosterone Replacement Therapy Market investigated in this report are: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2024

In the developing Markets of the Asia-Pacific, the Middle East, China, India, Japan and Australia, increased development prospects are to be expected due to the enormous potential in the individual countries. The various industry trends and threat factors are carefully examined and described in detail in this Testosterone Replacement Therapy report.

The study will also highlight the industrys key players, their product, business portfolio, Market share, financial status, regional share, segment sales, SWOT analysis, key strategies including mergers and acquisitions, product developments, joint ventures and partnerships, as well as improvements to their latest news.

In addition, this study will help our customers solve the following problems:

Cyclical Dynamics We forecast the dynamics of the industry through analytical and unconventional Market research approaches. Our customers use the information we provide to navigate Market uncertainty and disruption

Identifying Cannibalization Keys A major replacement for a product or service is the most common threat. Our customers can use our research findings to identify an important cannibalization of a Market. This helps them to prioritize their strategies for developing / delivering new products

Recognizing Emerging Trends Our range of ecosystems helps clients identify current Market trends. We also track possible impacts and disruptions that a Market would experience through a particular emerging trend. Our proactive analysis helps clients benefit from early intervention

Associated Opportunities With this report, customers can make decisions based on data, which increases the likelihood that the strategies in the real world will perform better, if not the best

For more information, see Download PDF Copy Here @ https://www.coherentmarketinsights.com/insight/request-pdf/2024

This study addresses some of the issues listed below:

How big is the Testosterone Replacement Therapy Market worldwide?

Which screen size is most preferred by consumers of Testosterone Replacement Therapy?

What type of distribution channel is most preferred by the producers of Testosterone Replacement Therapy?

What is the preferred age group for forwarding Testosterone Replacement Therapy to manufacturers?

What are the key factors that inhibit the growth of the Market, and to what extent are these factors affecting drivers and restraint systems?

How are the regulations affecting the growth of the Testosterone Replacement Therapy Market?

Which is the leading region / country for the growth of the Market? What is the expected growth rate of the leading regions in the forecasting period?

How will the emerging Testosterone Replacement Therapy Market develop in the coming years? How should the consumption pattern develop in the future?

Who are the main players in the global Testosterone Replacement Therapy Market? What is the current Market position of the key players? Who are the emerging players in this industry?

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Name: Mr. Raj Shah

Phone: US +12067016702 / UK +4402081334027

Email: [emailprotected]

Read the rest here:
Testosterone Replacement Therapy Market 2019-2027 Onset of Advanced Technologies to Upsurge the Growth - The Denton Chronicle

Testosterone Replacement Therapy Market Creating New Revenue Opportunities – Industry Updates Daily

Posted: November 12, 2019 at 2:47 pm

Overview

TMRs report on thetestosterone replacement therapy marketis an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services.

Our research report on the testosterone replacement therapy market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the testosterone replacement therapy market over the forecast period. These market indicators help businesses pave way in a crowded business landscape, and tread ahead in the competition with confidence.

Further, the report carries out solid groundwork and divulges details of markets share of key segments of the market under product, application, and geography.

To ascertain market indicators, analysts employed proven research tools and techniques for the same. The analysis of market indicators helps business carry out the most strategic planning for competitive advantage. These indicators also help businesses gauge investment proposition and scope of expansion in the testosterone replacement therapy market over the forecast period.

The report analyzes the competitive landscape of the testosterone replacement therapy market at length. The section includes detailed insights into key business strategies used by prominent players. Further, the report analyzes impact of growth strategies on the competitive dynamics and valuable insights into market share projections of key players in the testosterone replacement therapy market over the forecast period.

If you are stakeholder in the testosterone replacement therapy market, the analysis provided will help you understand growth model. Click to get a sample report in PDF (including ToC, Tables and Figures).

The report includes an exhaustive list of prominent players in the testosterone replacement therapy market:AbbVie, Inc., Allergan plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Mylan N.V., Novartis AG, and Pfizer, Inc.

For further know-how of competitive outlook, the report discusses SWOT analysis of prominent players, and how this will impact the competitive hierarchy until the end of the forecast period. This serves as a crucial market intelligence indicator to gauge growth strategies adopted by market stakeholders, and their stance on mergers, acquisitions, partnerships, and collaborations that can help remain competitive.

Key Questions Answered in the testosterone replacement therapy market Report

Go here to see the original:
Testosterone Replacement Therapy Market Creating New Revenue Opportunities - Industry Updates Daily

Acerus Pharmaceuticals (ASP) Set to Announce Earnings on Thursday – Polson News

Posted: November 12, 2019 at 2:47 pm

Acerus Pharmaceuticals (TSE:ASP) will be announcing its earnings results before the market opens on Thursday, November 14th.

TSE ASP opened at C$0.08 on Tuesday. The stocks fifty day moving average is C$0.10 and its two-hundred day moving average is C$0.12. The firm has a market capitalization of $20.90 million and a P/E ratio of -1.25. The company has a debt-to-equity ratio of 105.08, a quick ratio of 0.40 and a current ratio of 0.74. Acerus Pharmaceuticals has a fifty-two week low of C$0.07 and a fifty-two week high of C$0.21.

About Acerus Pharmaceuticals

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.

Recommended Story: Market Capitalization and Individual Investors

View post:
Acerus Pharmaceuticals (ASP) Set to Announce Earnings on Thursday - Polson News

Diet, body clock, hormones, and metabolism: What’s the link? – Medical News Today

Posted: November 12, 2019 at 2:46 pm

Using mice, scientists have revealed for the first time how stress hormones control fat and sugar levels over a 24-hour cycle. In addition, they have shown that a high calorie diet can alter the time-sensitivity of metabolic cycles.

The new study, led by researchers from Helmholtz Zentrum Mnchen and the German Center for Diabetes Research (DZD), also in Munich, Germany, helps to explain the rhythmic nature of stress hormones, whose levels surge before waking and feeding and ebb during sleep and fasting.

The findings also clarify how this hormonal cycle links to the daily routine that the liver follows in storing and releasing sugar and fat.

A recent Molecular Cell paper describes how the researchers made these discoveries by investigating glucocorticoid activity in the livers of mice.

Because the glucocorticoid receptor is also the target of anti-inflammatory synthetic steroids, the results suggest that glucocorticoid drugs could have different effects on people with and without obesity.

The adrenal glands release glucocorticoid hormones in the morning under the control of clock-related signals from the brain.

The biological clock that resides in every cell of the body helps to regulate the daily timing of hormone release. Sunlight and lifestyle factors help keep the biological clock in sync.

The glands also release the hormones in response to stress, which is why they are also called stress hormones.

The stress hormones reach their peak before waking, helping the body to prepare for the day's activities by getting energy from raised levels of fats and sugar.

However, disruption to biological clocks such as from working shifts or through jetlag can greatly upset metabolism and contribute to related disorders, such as type 2 diabetes, obesity, and fatty liver.

Glucocorticoid drugs and a condition called Cushing syndrome, both of which raise glucocorticoid levels, can have the same effect.

The new study aimed to understand the connection between the daily stress hormone surges, the biological clock, and metabolic cycles by focusing on glucocorticoid receptors.

Glucocorticoids regulate numerous molecular processes in functions ranging from metabolism and immunity to bone growth and cognition.

Nearly every cell of the body has receptors for these hormones. Without the matching receptor, the hormone cannot enter the cell and influence it.

For the new study, the team investigated the metabolic activity of glucocorticoids in the livers of mice by assessing the properties of their matching receptor.

They used a range of advanced techniques to map what happened to glucocorticoid receptors in mouse livers every 4 hours over a 24-hour cycle. They used two groups of mice: one group was on a normal diet, and the other group was fed a high fat diet.

The team also examined in detail what happened to the mice's 24-hour liver metabolism as a result of daily surges in glucocorticoid secretion.

The methods that they used allowed them to show that the effects of glucocorticoids were different when the animals fasted during sleep, and while they fed when they were awake and active.

The researchers found that the glucocorticoid receptor exerted these effects through time-sensitive binding with the genomes of the liver cells.

In addition, it appears that the receptor, and therefore the associated stress hormones, help regulate nearly all circadian genes.

"Highlighting the dominant role [the glucocorticoid receptor] plays in synchronizing circadian amplitudes," write the authors, "we find that the majority of oscillating genes are bound by and depend on [the glucocorticoid receptor]."

The researchers showed that the livers of mice that lacked the receptor did not control fat and sugar levels according to day and night.

The team suggests that the findings reveal how the liver controls levels of sugar and fat in the blood differently during the day compared with nighttime.

A further set of experiments also revealed that normal weight and obese mice responded differently to a glucocorticoid drug.

The team believes that the study is the first to show that diet can alter the effect of hormones and drugs on metabolic tissues.

The researchers suggest that their findings will help inform the emerging field of chronomedicine, which emphasizes the role of the biological clock in health and disease.

"We could describe a new link between lifestyle, hormones, and physiology at the molecular level, suggesting that obese people may respond differently to daily hormone secretion or to glucocorticoid drugs," says senior study author Nina Henriette Uhlenhaut, a professor at Helmholtz Zentrum Mnchen.

"Understanding how glucocorticoids control 24-hour cycles of gene activity in the liver and consequently blood levels of sugar and fat provides new insights into chronomedicine and the development of metabolic disease."

Prof. Nina Henriette Uhlenhaut

Follow this link:
Diet, body clock, hormones, and metabolism: What's the link? - Medical News Today

High blood pressure: Include this snack in your diet to lower your reading – Express

Posted: November 12, 2019 at 2:46 pm

Diet plays an essential role in lowering blood pressure and a growing body of evidence recommends certain foods for their blood pressure-lowering properties.

One study, published in the Journal of the American Heart Association, makes a strong case for supplementing a diet low in saturated fats with walnuts to help lower blood pressure.

In a randomised, controlled trial, researchers examined the effects of replacing some of the saturated fats in participants' diets with walnuts.

Saturated fat is the kind of fat found in butter, lard, ghee, fatty meats and cheese. Eating a diet high in saturated fat is associated with raised levels of non-HDL (bad) cholesterol, a waxy substance found in your blood that is tied to cardiovascular complications, explains the British Heart Foundation.

They found that when participants ate whole walnuts daily in combination with lower overall amounts of saturated fat, they had lower central blood pressure.

READ MORE:High blood pressure: The surprising food that could lower your reading

See more here:
High blood pressure: Include this snack in your diet to lower your reading - Express

Vegan Diet: Heres Whats Happening To Your Body When You Follow This Diet – Medical Daily

Posted: November 12, 2019 at 2:46 pm

There are numerous diet types that one can easily try to follow nowadays, but none are having their time in the limelight as much as the vegan diet, which since the year 2008, have increasingly been followed by people all over the world.

Of course, such a massive growth in self-described vegans would have different motivations, although most have something to do with environmental worries, religious reasons and animal welfare, since the diet is plant-based and shuns meat and dairy out the door.

But what actually goes through our body if we follow this diet? What good would it bring if we stick to it? We all know that plant-based diets are healthy but can be lacking. So whats the deal with veganism? Heres what you need to know:

First Couple Weeks

After the first couple weeks of going vegan, people will notice an energy boost. This is due to the removal of processed foods in our diet, and eating fruit and other plant-based options in their place, which then helps improve our mineral and fiber levels as well as our vitamins. Going weeks without animal products would also lead to a more regular bowel movement.

After Three to Six Months

By this time, its important that you take supplements to make up for lack of certain vitamins, which can only be taken from animal products. However, lack of processed foods can help clear up your acne, and a few months of a well-balanced vegan diet will do wonders for your cardiovascular health, reducing risk of strokes, diabetes and heart diseases. With that in mind, its still important to take supplements since the lack of animal-based protein is not recommended.

A Year Onwards

After a year of a vegan diet, some of our vitamin stores would have completely emptied out, unless we take supplements. All in all, a well-balanced vegan diet can have significant health benefits, but only if we offset its deficiencies by varying what we eat from time to time. When done with the correct preparation, however, the vegan diet is incredibly healthy for us people.

The vegan diet mainly provides very low fat but is high in carbohydrates. Pixabay

Read more:
Vegan Diet: Heres Whats Happening To Your Body When You Follow This Diet - Medical Daily

Want your diet to succeed during the holidays? – ABC 4

Posted: November 12, 2019 at 2:46 pm

Posted: Nov 11, 2019 / 04:47 PM MST / Updated: Nov 12, 2019 / 10:33 AM MST

SALT LAKE CITY, Utah (ABC4Utah) Are you a sugar-holic? Afraid of the sugar withdrawal? Dont worry. Its a rut that we all can get stuck in.

Unfortunately, 95% people fail at first when trying to lose weight. Melissa Pennington was one of those. She has now lost 33 pounds following Dr. Kells Weight Loss program. This time is worked for Melissa for several reasons. A laid-out diet that was easy to follow, healthy food, and the lifetime companionship of Dr Kells Weight Loss.

Dr. Kristen Kells knew something had to change in the weight loss industry. A program needed to address all aspects of the person losing weight. Biochemistry, physiology, and psychology. Dr. Kells was hearing these needs from everyone trying to succeed.

If you are wondering if this if for you, call (385) 217-6368 for a free, no-obligation consultation. If you sign up during the holidays, you will receive a free month. You can also visit DrKellsWeightLoss.com for more info.

This article contains sponsored content.

See the article here:
Want your diet to succeed during the holidays? - ABC 4


Page 1,280«..1020..1,2791,2801,2811,282..1,2901,300..»